FDA Approves ABSORICA LD — Sun Pharmaceutical Industries, Inc.
Sun Pharmaceutical Industries, Inc. secured FDA approval for oral isotretinoin brand Absorica LD, positioning the Indian pharma giant to capture significant market share within the lucrative dermatology sector and compete in the expanding acne treatment market.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day